Magnetic alginate core-shell nanoparticles based on Schiff-base imine bonding for pH-responsive doxorubicin delivery system

This research describes the development of a novel pH-responsive drug delivery system (DDS) based on sodium alginate (SA) and magnetic nanoparticles (MNPs) for cancer treatments. One possible approach to creating a wide variety of functional nanoparticles is to graft functional materials onto magnetite nanoparticles. In this study, we demonstrate the effective alteration of Fe3O4 nanoparticles using the alginate dialdehyde (ADA) group through a Schiff-Base imine reaction toward synthesizing Fe3O4@SiO2@APTMS@ADA (FSA@ADA) nanocarrier (NC). doxorubicin (DOX) as an anticancer drug was loaded (about 93% drug loading capacities) on the FSA@ADA NC through chemical and physical interactions. doxorubicin (DOX) as an anticancer drug was loaded (about 93% drug loading capacities) on the FSA@ADA NC through chemical and physical interactions. The synthesized nanocarriers were thoroughly characterized by various techniques, including FT-IR, FE-SEM, EDX-MAP, TEM, XRD, VSM, TGA, and 1HNMR. In vitro DOX release studies showed a pH-dependent manner and its release rate is lower (< 15%) at 7.4 than pH 5 (about 75%) over 25 days. Cytotoxicity results showed good biocompatibility for blank FSA@ADA (over about 85% cell viability), whereas DOX-loaded FSA@ADA NCs had higher cytotoxic effects (IC50 value: ~6 µg/mL) as a result of the controlled release of DOX into HeLa cells. Results showed that the magnetic core-shell FSA@ADA/DOX NC has the potential to be used as a targeted stimuli-responsive drug for cancer treatment.